Evidence map›Paper›PMID 23519988›Full record

ArticleStatistics in medicine2013

Integrative analysis of multiple cancer genomic datasets under the heterogeneity model.

Jin Liu, Jian Huang, Shuangge Ma

Erratum issuedAbstract read
In one paragraph

Article in Statistics in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors.

Jin LiuDepartment of Biostatistics, School of Public Health, Yale University, 60 College Street, New Haven, CT 06520, U.S.A.
Jian Huang
Shuangge Ma

Funding

Predicting Adjuvant Chemotherapy Response in Lung CancerR01CA152301 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2010 to 2014
$1.5M
Novel Methods for Integrative Analysis of Cancer Genomic DataR01CA142774 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE · 2010 to 2013
$1.3M
Robust rank-based methods and detection of GXE in cancer etiology and survivalR21CA165923 · NCI · YALE UNIVERSITY · PI MA, SHUANGGE, ZHANG, YAWEI · 2012 to 2014
$421k
NCI NIH HHS CA142774NCI NIH HHS CA152301NCI NIH HHS CA165923NCI NIH HHS R01 CA142774NCI NIH HHS R01 CA152301NCI NIH HHS R21 CA165923
6 · The paper itself

Abstract

In the analysis of cancer studies with high-dimensional genomic measurements, integrative analysis provides an effective way of pooling information across multiple heterogeneous datasets. The genomic basis of multiple independent datasets, which can be characterized by the sets of genomic markers, can be described using the homogeneity model or heterogeneity model. Under the homogeneity model, all datasets share the same set of markers associated with responses. In contrast, under the heterogeneity model, different studies have overlapping but possibly different sets of markers. The heterogeneity model contains the homogeneity model as a special case and can be much more flexible. Marker selection under the heterogeneity model calls for bi-level selection to determine whether a covariate is associated with response in any study at all as well as in which studies it is associated with responses. In this study, we consider two minimax concave penalty-based penalization approaches for marker selection under the heterogeneity model. For each approach, we describe its rationale and an effective computational algorithm. We conduct simulations to investigate their performance and compare with the existing alternatives. We also apply the proposed approaches to the analysis of gene expression data on multiple cancers.

Indexed as

AlgorithmsData Interpretation, StatisticalModels, StatisticalBiomarkers, TumorComputer SimulationGene Expression ProfilingGenomicsHumansNeoplasmsOligonucleotide Array Sequence AnalysisBiomarkers, Tumorheterogeneity modelintegrative analysismarker selection

Identifiers

PMID23519988
PMCPMC3743947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.